article thumbnail

CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

DAIC

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. The Paradise uRDN system is intended as an adjunctive treatment option when lifestyle changes and medications have not adequately controlled a patient’s blood pressure.

CMS 40
article thumbnail

Revolutionizing Hypertension Treatment: The Promise of Renal Denervation

Wellnest

These groundbreaking developments offer a paradigm shift in the management of resistant hypertension, especially when it is extremely difficult to achieve blood pressure control through conventional means, such as lifestyle modifications and various drug therapies.

article thumbnail

Recor Medical’s Paradise Renal Denervation System Lands FDA Approval

CardiacWire

That could be huge for these millions of patients, and for Recor Medical, which is now the clear frontrunner in what might prove to be a multi-billion dollar market.

article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 2) 

Cardiometabolic Health Congress

The results reinforced the importance of the teamwork approach outlined in Part 1: MDT patients achieved greater weight loss More significant reductions in Body Mass Index (BMI) Larger decreases in blood pressure Improved hemoglobin A1C levels This study underscores the effectiveness of leveraging diverse expertise, such as internal medicine, (..)